Rainy home

A few nice weight loss advice images I found:

These are useful by me!,This is about Boat Shoes and Girls Casual Dresses.OK!
Beautiful:

Beware of Fat, Metropolitan Life Insurance, 1924

Image by chamisa flower
From the August 1924 issue of Century Magazine.

So much of this could have been written today.

My edited the following,This is about Diet Advice and Exercise Tips.OK!
Beautiful:

Metamfetamin 5 mg

Image by ADHD CENTER
Metamfetamin kan brukas
Bipacksedel
Information till förskrivare
Diskutera här påFlickr om metamfetamin alltid behöver vara bra eller dåligt, eller om det finns mera nyanserade sätt att se på det hela.

Metamfetamin kan missbrukas och
-Metamfetamin kan missbrukas: se konsekvenserna
och missbruket ökar snabbt. Speciellt farligt för personer med ADHD då missbruk av metamfetamin reglerar ned densiteten på dopaminreceptorerna.

Metamfetamin – the faces of meth
Klassiker om vad som händer med metamfetaminmissbrukaren, åldrandet och tänderna. Blicken, huden och ödesränderna.

Meth större hjärna med mindre innehåll
Vad som händer i hjärnan hos Meth missbrukare, hjärnan växer på grund av att den svullnar och densiteten på dopaminreceptorerna regleras ned. Men också att metamfetamin rätt använt kan vara bra samt varför. Skillnaden mellan enantiomererna hur hur otroligt olika de verkar.

Metamfetamin & ADHD + Hel dokumentär
Hel dokumentärfilm från National Geographic om världens farligaste drog: Metamfetamin,

Den här dokumentären kanske om inte annat kan förklara lite av varför Metamfetamin fått det rykte som det har, vilka konsekvenserna av ett missbruk blir osv. Ãven om dokumentären inte alls förklarar att personer med ADHD löper en ökad risk att fastna i ett metamfetaminmissbruk och att det på sikt kommer att göra problemen mycket värre tack vare att höga doser reglerar ned antalet och densiteten på dopamin receptorerna. Så att det som frälser dig också kommer att döda dig har kanske aldrig varit sannare än här.

Metamfetamin de direkta & indirekta skadeverkningarna
-Se Oprahshow nedan om metamfetaminmissbruk
-ohämmad sex med främlingar och sambanden

Fler och fler rapporter kommer om metamfetamin eller crystal meth som en del föredrar att kalla det men skadeverkningarna av ett missbruk direkt säger kanske inte så mycket om de indirekta skadeverkningarna av missbruket, vilket varit väldigt vanligt och utbrett i vissa kretsar i bland annat New York.

Marknadsföringen av Meth amfetamin till gravida
Den Pengakåta pillerindustrin har genom åren haft en rad smaklösheter för sig förutom att dölja resultat som talar till sitt preparats nackdel så manipuleras och har det manipulerats en hel del igenom åren. En speciellt intressant grupp att kränga "de nya supervetenskapliga" produkterna till har varit kvinnor, ofta med någon skavank som medicinjättarna inte alls varit sena med att marknadsföra med vetenskap som täckmantel. Det kan vara den feta kvinnan, den okåta kvinnan, den otacksamma kvinnan eller bara kvinnan som inte hinner med att städa rent i hemmet. Eller varför inte suggan som blivit på smällen och fettnat till? Behöver inte hon lite metamfetamin?

så här farligt lever användarna

Metamfetamin utbrett i hela skåne

ny dödsdrog sprider ut sig

DN Metamfetamin 1 2 3

SvD 1 2 3 4 5

Sydsvenskan 1 2 3

Produktbeskrivning på Engelska

METH
Teratogenic effects: Pregnancy Category C. Methamphetamine has been shown to have teratogenic and embryocidal effects in mammals given high multiples of the human dose. There are no adequate and well-controlled studies in pregnant women. METH tablets should
not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus. Nonteratogenic effects: Infants born to mothers dependent on amphetamines have an increased risk of premature delivery and low birth weight. Also, these infants may experience symptoms of withdrawal as demonstrated by dysphoria, including agitation and significant lassitude.

Usage in Nursing Mothers: Amphetamines are excreted in human milk. Mothers taking amphetamines should be advised to refrain from nursing.
Pediatric Use: Safety and effectiveness for use as an anorectic agent in children below the age of 12 years have not been established. Long-term effects of methamphetamine in children have not been established (see WARNINGS). Drug treatment is not indicated in all cases of the behavioral syndrome characterized by moderate to severe distractibility, short attention span, hyperactivity, emotional lability and impulsivity. It should be considered only in light of the complete history and evaluation of the child. The decision to prescribe METH tablets should depend on the physicianâs assessment of the chronicity and severity of the childâs symptoms and their appropriateness for his/her age. Prescription should not depend solely on the presence of one or more of the behavioral characteristics. When these symptoms are associated with acute stress reactions, treatment with METH tablets is usually not indicated. Clinical experience suggests that in psychotic children, administration of METH tablets may exacerbate symptoms of behavior disturbance and thought disorder. Amphetamines have been reported to exacerbate motor and phonic tics and Touretteâs syndrome. Therefore, clinical evaluation for tics and Touretteâs syndrome in children and their families should precede use of stimulant medications.

ADVERSE REACTIONS
The following are adverse reactions in decreasing order of severity within each category that have been reported: Cardiovascular: Elevation of blood pressure, tachycardia and palpitation. Fatal cardiorespiratory arrest has been reported, mostly in the context of abuse/misuse. Central Nervous System: Psychotic episodes have been rarely
eported at recommended doses. Dizziness, dysphoria, overstimulation, euphoria, insomnia, tremor, restlessness and headache. Exacerbation of motor and phonic tics and Touretteâs syndrome. Gastrointestinal: Diarrhea, constipation, dryness of mouth, unpleasant taste and other gastrointestinal disturbances.
Hypersensitivity: Urticaria.
Endocrine: Impotence and changes in libido.
Miscellaneous: Suppression of growth has been reported with the
long-term use of stimulants in children (see WARNINGS).
DRUG ABUSE AND DEPENDENCE
Controlled Substance: METH tablets are subject to control under
DEA schedule II.

Abuse: Methamphetamine has been extensively abused. Tolerance, extreme psychological dependence, and severe social disability have occurred. There are reports of patients who have increased the dosage to many times that recommended. Abrupt cessation following prolonged high dosage administration results in extreme fatigue and mental depression; changes are also noted on the sleep EEG. Manifestations of chronic intoxication with methamphetamine include
severe dermatoses, marked insomnia, irritability, hyperactivity, and personality changes. The most severe manifestation of chronic intoxication is psychosis often clinically indistinguishable from schizophrenia. Abuse and/or misuse of methamphetamine have resulted in death. Fatal cardiorespiratory arrest has been reported in the context of abuse and/or misuse of methamphetamine.

OVERDOSAGE depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression. Emergence of New Psychotic or Manic Symptoms: Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania can be caused by stimulants at usual doses. If such symptoms occur, consideration should be given to a possible causal role of the stimulant, and discontinuation of
treatment may be appropriate. In a pooled analysis of multiple short-term, placebo-controlledstudies, such symptoms occurred in about 0.1% (4 patients with events out of 3482 exposed to methylphenidate or amphetamine for several weeks at usual doses) of stimulant-treated patients compared to 0 in placebo-treated patients.
Aggression: Aggressive behavior or hostility is often observed in children and adolescents with ADHD, and has been reported in clinical trials and the postmarketing experience of some medications indicated for the treatment of ADHD. Although there is no systematic evidence that stimulants cause aggressive behavior or hostility, patients beginning treatment for ADHD should be monitored for the appearance of or worsening of aggressive behavior or hostility. There is some clinical evidence that stimulants may lower the convulsive threshold in patients with prior history of seizures, in patients with prior EEG abnormalities in absence of seizures, and, very rarely, in patients without a history of seizures and no prior EEG evidence of seizures. In the presence of seizures, the drug should be discontinued. Visual Disturbance Difficulties with accommodation and blurring of vision have been reported with stimulant treatment.

PRECAUTIONS
General: METH tablets should be used with caution in patients with even mild hypertension. Methamphetamine should not be used to combat fatigue or to replace rest in normal persons. Prescribing and dispensing of methamphetamine should be limited to the smallest amount that is feasible at one time in order to minimize the possibility of overdosage. Information for Patients: The patient should be informed that methamphetamine may impair the ability to engage in potentially hazardous activities, such as, operating machinery or driving a motor vehicle.

The patient should be cautioned not to increase dosage, except on advice of the physician. Prescribers or other health professionals should inform patients, their families and their caregivers about the benefits and risks associated with treatment with methamphetamine and should counsel them it its appropriate use. A patient Medication Guide is available for METH. The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.

Drug Interactions: Insulin requirements in diabetes mellitus may be altered in association with the use of methamphetamine and the concomitant dietary regimen. Methamphetamine may decrease the hypotensive effect of guanethidine. METH should not be used concurrently with monoamine oxidase inhibitors (see CONTRAINDICATIONS). Concurrent administration of tricyclic antidepressants and indirect- acting sympathomimetic amines such as the amphetamines, should be closely supervised and dosage carefully adjusted. Phenothiazines are reported in the literature to antagonize the CNS stimulant action of the amphetamines.

INDICATIONS AND USAGE
Attention Deficit Disorder with Hyperactivity: METH tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. Exogenous Obesity: as a short-term (i.e., a few weeks) adjunct in a regimen of weight reduction based on caloric restriction, for patients in whom obesity is refractory to alternative therapy, e.g., repeated diets, group programs, and other drugs. The limited usefulness of METH tablets (see CLINICAL PHARMACOLOGY) should be weighed against possible risks inherent in use of the drug, such as those described below.

CONTRAINDICATIONS
METH tablets are contraindicated during or within 14 days following the administration of monoamine oxidase inhibitors; hypertensive crisis may result. It is also contraindicated in patients with glaucoma, advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism or known hypersensitivity or idiosyncrasy to sympathomimetic amines. Methamphetamine should not be given to patients who are in an agitated state or who have a history of drug abuse.

WARNINGS
Tolerance to the anorectic effect usually develops within a few weeks. When this occurs, the recommended dose should not be exceeded in an attempt to increase the effect; rather, the drug should be discontinued (see DRUG ABUSE AND DEPENDENCE).
Serious Cardiovascular Events
Sudden Death and Pre existing Structural Cardiac Abnormalities
or Other Serious Heart Problems:
Children and Adolescents: Sudden death has been reported in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems. Although some serious heart problems alone carry an increased risk of sudden death, stimulant products generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the sympathomimetic effects of a
stimulant drug.
Adults: Sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, or other serious cardiac problems. Adults with such abnormalities should also generally not be treated with stimulant drugs. Hypertension and other Cardiovascular Conditions: Stimulant medications cause a modest increase in average blood pressure (about 2-4 mmHg) and average heart rate (about 3-6 bpm), and individuals may have larger increases. While the mean changes alone would not be expected to have short-term consequences, all patients should be monitored for larger changes in heart rate and blood pressure. Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate, e.g., those with pre-existing hypertension, heart failure, recent myocardial infarction, or ventricular arrhythmia. Assessing Cardiovascular Status in Patients being Treated with Stimulant Medications: Children, adolescents, or adults who are being considered for treatment with stimulant medications should have a careful history (including assessment for a family history of sudden death or ventricular arrhythmia) and physical exam to assess for the presence of cardiac disease, and should receive further cardiac evaluation if findings suggest such disease (e.g., electrocardiogram and echocardiogram). Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during stimulant treatment should undergo a prompt cardiac evaluation.
Psychiatric Adverse Events
Pre-existing Psychosis:
Administration of stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with a pre-existing psychotic disorder. Bipolar Illness: Particular care should be taken in using stimulants to treat ADHD in patients with comorbid bipolar disorder because of concern for possible induction of a mixed/manic episode in suchpatients. Prior to initiating treatment with a stimulant,

METH®
Methamphetamine
Hydrochloride
Tablets, USP only

DESCRIPTION
METH® (methamphetamine hydrochloride tablets, USP), chemically known as (S)-N,α-dimethylbenzeneethanamine hydrochloride, is a member of the amphetamine group of sympathomimetic amines. It has the following structural formula:

CLINICAL PHARMACOLOGY
Methamphetamine is a sympathomimetic amine with CNS stimulant activity. Peripheral actions include elevation of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. Drugs of this class used in obesity are commonly known as âanorecticsâ or âanorexigenicsâ. It has not been established, however, that the action of such drugs in treating obesity is primarily one of appetite suppression. Other central nervous system actions, or metabolic effects, may be involved, for example. Adult obese subjects instructed in dietary management and treated with âanorecticâ drugs, lose more weight on the average than those treated with placebo and diet, as determined in relatively short-term clinical trials.
The magnitude of increased weight loss of drug-treated patients over placebo-treated patients is only a fraction of a pound a week. The rate of weight loss is greatest in the first weeks of therapy for both drug and placebo subjects and tends to decrease in succeeding weeks. The origins of the increased weight loss due to the various possible drug effects are not established. The amount of weight loss associated with the use of an âanorecticâ drug varies from trial to trial, and the increased weight loss appears to be related in part to variables other than the drug prescribed, such as the physician-investigator, the population treated, and the diet prescribed. Studies do not permit conclusions as to the relative importance of the drug and non-drug factors on weight loss.

The natural history of obesity is measured in years, whereas the studies cited are restricted to a few weeks duration; thus, the total impact of drug-induced weight loss over that of diet alone must be considered clinically limited. The mechanism of action involved in producing the beneficial behavioral changes seen in hyperkinetic children receiving methamphetamine is unknown. In humans, methamphetamine is rapidly absorbed from the gastrointestinal tract. The primary site of metabolism is in the liver by aromatic hydroxylation, N-dealkylation and deamination. At least seven metabolites have been identified in the urine. The biological half-life has been reported in the range of 4 to 5 hours. Excretion occurs primarily in the urine and is dependent on urine pH. Alkaline urine will significantly increase the drug half-life. Approximately 62% of an oral dose is eliminated in the urine within the first 24 hours with about one-third as intact drug and the remainder as metabolites.

METHAMPHETAMINE HAS A HIGH POTENTIAL FOR
ABUSE. IT SHOULD THUS BE TRIED ONLY IN
CLINICAL PHARMACOLOGY. HAVE A NICE DAY.

Bara metylfenidat rekommenderas av de europeiska kontrollmyndigheterna för behandling av ADHD

My edited the following,This is about Cotton Dress and Girls Casual Dresses.OK!
This following not about weight loss advice,But funny：A bad workman always blames his toolsThere are painters who transform the sun to a yellow spot, but there are others who with the help of their art and their intelligence, transform a yellow spot into the sun. (Picasso, Spanish painter)When two‘s company, three‘s the result! Caution is the parent of safety..Every man is the architect of his own fortune.。OK！good!！Refinement :

Brugge

Image by inyucho
Good to have someone who gives health advice so close to the Chocolate Museum…

A few nice weight loss advice images I found:

Hi,I did the following:,This is about Boat Shoes and Exercise Tips.OK!
Refinement :

In Memoriam: Dr. Ronald Walters

Image by University of Maryland Press Releases
"What was most impressive about him was that he was such a humble man, even in all of his fame."
- Dr. Nina Harris, UM School of Public Policy

Professor Emeritus Ronald Walters, an internationally recognized political scientist, died on September 10 after a long illness. He was 72.

Arrangements for a memorial service have not yet been announced.
Walters had an illustrious career as a teacher, writer, researcher and political activist. He played major roles in the presidential campaigns of the Rev. Jesse Jackson, and earned many prestigious academic, publishing and service awards.

Walters wrote a weekly syndicated column of political commentary that appeared in newspapers around the nation. He remained a powerful intellectual and political force until his death.

"Ron Walters was an eminent and inspiring professor, teacher, author, mentor and human being," said Acting University President Nariman Farvardin. "He had a great impact and made a real difference in the world and to all those who knew him. His death is a tremendous loss. Our sincerest condolences go out to his wife, Patricia, and all his family."

"Professor Walters was a scholarly giant," said California Congresswoman Barbara Lee, chair of the Congressional Black Caucus. "His scholarly work and sound advice, have assisted many past and present members of the Congressional Black Caucus, and other African American political and civic leaders around the country."

This past August, in Walters’ last syndicated column, he shared his view from the mountain, recalling Washington in August, 1963, and the "progressive spirit of the original nonviolent march, which held out the hope of racial reconciliation, and that America would finally cash a check of justice that would allow all of us to invest in the great project of democracy."

Then, Dr. Walters reminded his readers that there is still "work to be done…at home," and that African Americans "should try out their local mobilization legs" to prepare for the fall elections. The stakes will be high, he reminded – "jobs and justice and respecting the values of the movement for which so many people gave their lives, time and energy."

In 1958, as a youth leader in the Wichita NAACP, Walters organized a successful sit-in to protest segregation at a local drugstore – two years before the better-known Greensboro sit-ins, adds Maryland colleague, Tamara Wilds Lawson.

Before retiring from full-time work in July of 2009, Walters carried three major titles at the University of Maryland: Director of the African American Leadership Institute, distinguished leadership scholar at the James MacGregor Burns Academy of Leadership, and professor of government and politics. He was internationally known for his expertise on African American leadership and politics, his writing, and his teaching.
"Ron was an inspiration to all, especially those aspiring to be future leaders," recalls his Academy colleague, Nina Harris. "He touched the lives of students through his teaching and mentoring and will be missed by so many. There was a constant stream of media setting up in the Academy of Leadership Library to conduct interviews but yet he seemed unfazed by it all. He was a part of our family, and I am grateful that I was able to be a part of his journey."

One of Walters’ former students, makes a similar point. Baltimore Congressman Elijah Cummings calls him a mentor, whose classes were extremely popular, even though he was a tough grader.

"While he was a quiet man, his opinions always carried a lot of weight in the world of politics and beyond," Cummings said in a statement. "He was a man who consistently told me what I needed to hear even though I may not have wanted to hear it. He touched the lives of all the students who had the honor of being a part of any of his classes."

Walters is survived by his wife, Patricia Ann Walters.

CAREER

Walters’ career blended academic achievement, a bookshelf of publications and significant political activity. He held senior positions in both of Rev. Jesse Jackson’s runs for the White House and lived to see the first African American elected to the U.S. presidency.

"Dr. Ron Walters was the preeminent activist and scholar of our times," Jackson recalled to the Chicago Defender. "The good news is that Ron taught so many scholars. There are those who will now bear truth. So, that tradition will be kept alive."

In 1984, he served the Jackson campaign as deputy campaign manager for issues, and held a similar post in 1988.

Walters received his Bachelor of Arts degree in History and Government with Honors from Fisk University (1963) and both his M.A. in African Studies (1966) and Ph.D. in International Studies (1971) from American University.

Prior to coming to the University of Maryland in 1996, Walters served as professor and chair of the political science department at Howard University, assistant professor and chair of Afro-American studies at Brandeis University, and assistant professor of political science at Syracuse University. Also, he served as visiting professor at Princeton University and as a fellow of the Institute of Politics at the Kennedy School of Government, Harvard University.

Walters was a former member of the governing council of the American Political Science Association. Walters also served as the senior policy staff member for Congressman Charles Diggs, Jr. and Congressman William Gray.

He served as board member of the Black Leadership Forum, the National Coalition of Black Civic Participation, and other organizations.

PUBLICATIONS

Dr. Walters wrote over 100 articles and ten books. His book, Black Presidential Politics in America, (1989), won the American Political Science Association’s Ralph Bunche Prize and the Best Book award from the National Conference of Black Political Scientists (NCOBPS). Pan Africanism in the African Diaspora (1993) also won the NCOBPS Best Book award.

His most recent books were White Nationalism, Black Interests: Conservative Public Policy and the Black Community (2003), Freedom Is Not Enough: Black Voters, Black Candidates, and American Presidential Politics (2005), and The Price of Racial Reconciliation (2008).

The University of Maryland libraries summarizes some of his major publications online.

RECOGNITION

Walters won many awards, including a distinguished faculty award from Howard University (1982), Distinguished Scholar/Activist Award, Black Scholar Magazine (1984), W.E.B. DuBois/Frederick Douglass Award, African Heritage Studies Association (1983), the Ida Wells Barnett Award, Association of Black School Educators, (1985), the Fannie Lou Hammer Award, National Conference of Black Political Scientists (1996), Distinguished Faculty Contributions to Campus Diversity, University of Maryland (1999), and the Ida B. Wells-W.E.B. DuBois Award for Distinguished Scholarship from the National Council for Black Studies (2000).

He was awarded the honor of "Alumnus of the Year" by the School of International Service of the American University in 2000.

Walters frequently appeared on local and major media as an analyst of African American politics, such as CNN, CBS News, Nightline, NBC Today Show, C-SPAN, the PBS Newshour and Think Tank, and All Things Considered (NPR). Walters wrote a weekly opinion column for the National Newspaper Publishers Association News Service and Web sites.

A number of memorial services are planned, including one in his home town of Wichita.

Media Contact:

Neil Tickner, 301 405 4622 or ntickner@umd.edu

This following not about weight loss advice,But funny：A bad beginning makes a bad ending. A friend is easier lost than found.God made relatives; Thank God we can choose our friends. One meets its destiny on the road he takes to avoid it..To make something special, you just have to believe it’ s special。OK！good!！Beautiful:

possible earning opportunity

Image by mike-andrews

tips:
This following not about weight loss advice,But funny：A boaster and a liar are cousins-german.An ounce of luck is better than a pound of wisdom.Children in backseats cause accidents. Accidents in backseats cause children. There are no accidents..Love the neighbor. But don‘t get caught.。OK！END！Question–: Is doing the opposite of weight loss advice healthy for skinny people to gain weight?
I’m a skinny guy (im 17, 130 pounds), but pretty athletic. If I want bigger arms & calfs, in general want to gain more weight. If I follow the opposite of weight loss advice, such as not exercising and eating foods like cake/donuts, (along with obviously protein shakes, will I gain muscle mass?

Another thing I want to ask is if “high protein” but low calorie whey protein drinks (this thing called Orgaino is healthy for me.

The following is the answer: (Hint: The answer is not necessarily.)

Answer by Johnny Ma
If you want to gain muscle mass, you’re going to have to start hoisting metal- lots of it! Those muscle gain powder mixes will help, but read the caloric info on the back- lots of them have tons of fat and sugar. May I suggest eating natural proteins (lean cuts of beef, chicken and fish) along with a balanced health diet of fresh fruits, veggies, and non-white 100% whole wheat carbs.

Answer by Steven Rameriz
You needd to be big just workout because that make you bigger

Answer by JohnT
Im practically on your same case but i do know that doing the opposite is not completely healthy because eating a lot of fat and sugar might give you problems.. try eating a lot of proteins and a balanced diet (not being shy on carbs but not exaggerating either) and doing excercises

Answer by Steve
Well you aren’t really eating healthy. You still want to have a balanced diet otherwise you will probably just end up with a gut and looking skinny everywhere else.

Answer by Divya Joy
try acai

Answer by Colene Waniewski
I recommend this site. This should help you. But please avoid trying losing weight if you are pregnant or breastfeeding. I lost 15 pounds in a month with the help of the article below.

Know better? Leave your own answer in the comments!

Leave a Reply